Revolution Medicines, Inc. Warrant (RVMDW) financials · $1.88B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Revolution Medicines, Inc. Warrant (RVMDW) $1.88B cap.
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | — | — | |
| Operating Income | −$1.18B | −$689.52M | |
| Net Income | −$1.13B | −$600.09M | |
| EPS (Diluted) | −$5.95 | −$3.58 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $2.35B | $2.56B | |
| Current Assets | $2.08B | $2.33B | |
| Cash & Equivalents | $383.75M | $543.06M | |
| PP&E | $33.19M | $24.29M | |
| Total Liabilities | $723.21M | $293.10M | |
| Current Liabilities | $290.42M | $163.91M | |
| Shareholders' Equity | $1.63B | $2.27B | |
| Retained Earnings | −$2.87B | −$1.74B |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$897.74M | −$557.44M | |
| CapEx | $15.99M | $10.31M | |
| Investing Cash Flow | $118.06M | −$554.39M | |
| Financing Cash Flow | $621.52M | $959.41M | |
| Net Change in Cash | −$158.16M | −$152.42M | |
| Free Cash Flow | −$913.73M | −$567.74M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is RVMDW P/E and revenue?
Revolution Medicines, Inc. Warrant (RVMDW) $1.88B cap.
What is RVMDW revenue?
RVMDW income-statement cache has no revenue figure yet.
Is RVMDW profitable?
Revolution Medicines, Inc. Warrant last cached net income is -$1.13B (FY2025).
What are RVMDW total assets?
Revolution Medicines, Inc. Warrant last cached total assets are $2.35B (FY2025).
What is RVMDW free cash flow?
Revolution Medicines, Inc. Warrant last cached free cash flow is -$913.7M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.